Synthgene Company Introduction

AVO is the oversea subsidiary of Jiangsu Synthgene Biotechnology Co., Ltd.

Over the years, Synthgene is committed to the development and industrialization of life science insurmountable raw materials. Currently, Synthgene antibody discovery platform, mRNA stock solution preparation platform, mRNA-LNP preparation process platform, oligonucleotide preparation platform, enzyme directed evolution platform contribute to derivative segments include cell gene therapy, raw materials, gene nucleic acid, drug raw materials and IVD raw materials. The company has been selected to cultivate unicorn enterprises in Nanjing and raised hundreds of millions in RMB.

We, as your trustworthy partner, help you strengthen your commercial, ease transfers to manufacturing, secure continuous production, and create consistently high standard products.